YOLFTbeta
07

Daebongls.Co.Ltd

078140 · KQ · Healthcare / Pharmaceuticals

6,460.00KRW-70.00 (-1.07%)

Price History

Full chart

Market Stats

Previous Close6,530.00
Open6,560.00
Day Range6,440.00 – 6,650.00
52-Week Range6,780.00 – 13,114.85
Volume8.28K
Market Cap83.21B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.42%
Beta0.97
50-Day Avg7,808.40
200-Day Avg9,648.10

About

Daebongls.Co.,Ltd. engages in the research, development, and production of cosmetics, pharmaceutical raw materials, food and feed products in South Korea and internationally. The company's Cosmetic Ingredients division offers special cosmetic ingredients comprising fresh green tea, black ginseng water, jeju hatban extract, wormwood extract, jeju camellia oil, jeju dang oil extract, jeju basalt powder, jeju active complex, and ginseng flower extract; and natural and synthesis cosmetics like moisturizing, skin protection, whitening, anti- aging, skin care, and hair care products. The company's Pharmaceutical Raw Material division develops the API of respiratory, hypertension, digestive-system treatments, and medicines and supply excipients to domestic companies as an agent for global companies. The company's Food & Feed division manufactures and distributes functional additives, protein products, amino acids, and vitamins. Daebongls.Co.,Ltd. was founded in 1986 and is headquartered in Incheon, South Korea.

Company Details

  • SectorHealthcare
  • IndustryPharmaceuticals
  • CEOMr. Jin-Oh Park
  • Employees123
  • Headquarters123 Neungheodae-ro 649 beon-gil, Incheon, South Korea, 21697, Korea
  • Websitehttps://www.daebongls.co.kr

Leadership

  • Mr. Jin-Oh ParkChief Exec. Officer · b. 1971
  • Mr. Jong-Ho ParkFounder
  • Mr. Chang-Woo SonDirector of Fin. Management Department and Director · b. 1967
  • Mr. Yong-Kil KimChief of R&D and Director · b. 1960

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue37.98B44.37B43.78B52.15B58.65B71.04B65.65B71.82B69.54B76.25B82.96B93.50B87.62B93.95B102.06B
Growth (%)-+16.83%-1.35%+19.13%+12.45%+21.13%-7.58%+9.40%-3.18%+9.66%+8.79%+12.71%-6.29%+7.23%+8.63%
Cost of Revenue31.25B35.91B31.87B39.17B43.50B50.77B46.15B52.72B50.66B55.58B59.38B68.55B66.18B67.16B73.57B
Gross Profit---12.21B15.14B20.27B19.50B19.11B18.88B20.67B23.58B24.96B21.44B26.80B28.49B
Gross Margin---23.41%25.82%28.53%29.70%26.60%27.15%27.11%28.42%26.69%24.47%28.52%27.92%
Operating Expense---5.84B6.64B9.08B10.36B11.18B11.70B12.55B13.89B16.78B17.64B17.74B21.16B
Operating Income2.66B3.56B6.12B6.36B8.50B11.19B9.14B7.92B7.18B8.12B9.69B8.17B3.80B9.05B7.33B
Operating Margin7.00%8.02%13.97%12.20%14.49%15.76%13.92%11.03%10.33%10.65%11.68%8.74%4.34%9.64%7.18%
EBITDA-----------14.33B10.35B14.60B21.04B
EBITDA Margin-----------15.32%11.81%15.54%20.62%
Net Income3.15B3.37B4.99B5.45B7.15B8.39B7.14B6.22B5.73B5.82B6.79B8.63B4.18B7.34B10.06B
Net Income Margin8.29%7.59%11.41%10.44%12.19%11.81%10.87%8.66%8.24%7.63%8.18%9.23%4.77%7.81%9.86%
R&D937.90M-1.40B1.71B2.02B2.73B3.10B3.12B-3.62B3.81B5.12B5.13B5.25B5.62B
R&D as % of Total Revenue2.47%-3.20%3.28%3.45%3.84%4.72%4.34%-4.74%4.60%5.47%5.86%5.59%5.51%
Interest Expense000000000137.23M39.68M499.27M641.97M40.78M1.82B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.18%0.05%0.53%0.73%0.04%1.79%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets43.84B46.55B51.03B56.65B65.47B75.43B80.45B86.93B102.13B149.79B163.24B186.14B194.92B238.71B264.96B
Total Liabilities7.28B7.00B6.79B7.29B10.28B12.50B11.22B12.31B21.32B46.04B53.84B68.98B41.69B106.95B90.05B
Total Equity36.43B39.26B43.70B48.59B55.19B62.92B69.23B74.62B80.81B103.75B109.40B117.16B120.73B131.77B141.21B
Cash2.62B2.11B3.00B2.33B4.80B5.55B12.03B9.26B1.58B9.99B14.42M16.90M14.18B12.25M7.62B
Total Debt----712.00M845.63M508.67M325.33M6.22B5.99B-----
Net Debt----------2.95B17.15B15.48B30.83B63.33B

Cash Flow

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow2.93B-5.11B2.52B8.75B7.53B8.41B8.77B6.05B15.70B10.10B8.78B5.89B14.34B8.91B
Investing Cash Flow-1.01B--2.72B-6.12B-6.36B652.76M-10.79B-10.57B-55.49B-16.12B-21.78B-2.23B-30.58B-
Financing Cash Flow----457.23M-154.33M-424.25M-2.16B-737.66M6.98B38.16B2.15B14.04B3.34B20.14B-
Capital Expenditure631.38M738.34M1.20B622.11M769.11M3.54B3.92B3.60B7.16B8.57B6.32B5.67B9.59B26.49B39.63B
Free Cash Flow---------7.03B3.68B3.10B-3.70B-12.15B-30.72B
Dividends Paid476.10M553.09M554.33M554.33M554.33M554.33M554.33M554.33M554.33M554.33M550.51M1.03B999.99M926.49M1.02B
FCF to OCF---------44.75%36.42%35.35%-62.78%-84.73%-344.95%
Dividend Paid to FCF---------7.89%14.97%33.19%-27.05%-7.63%-3.32%

Earnings

Report DateMar 31, 2006Jun 30, 2006Sep 30, 2006Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Dec 1, 2014Mar 20, 2015May 14, 2015Aug 4, 2015Nov 3, 2015Feb 1, 2016May 3, 2016Jul 26, 2016Oct 27, 2016Feb 3, 2017Apr 27, 2017Aug 7, 2017Oct 31, 2017Feb 14, 2018May 2, 2018Aug 8, 2018Nov 14, 2018Feb 25, 2019May 10, 2019Aug 13, 2019Nov 14, 2019Feb 27, 2020May 12, 2020Aug 2, 2020Nov 15, 2020Mar 2, 2021May 16, 2021Aug 17, 2021Nov 15, 2021Feb 15, 2022May 11, 2022Aug 8, 2022Nov 14, 2022Mar 21, 2023Mar 31, 2023Jun 30, 2023Sep 30, 2023Mar 28, 2024Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------137.00221.00196.00212.00214.00-------------------------------------
EPS Actual57.2155.0048.6086.37106.7875.67120.8693.88123.3369.1495.3854.7354.85102.4869.7641.2145.0376.96106.81100.83128.13114.72121.62165.56105.6898.35105.00192.83140.22207.03175.00259.00190.00134.00202.00135.30152.00151.63155.00211.0087.00108.00122.00170.59131.2892.32171.00191.00148.0016.51132.00182.00173.00131.84212.00123.00-30.00482.67150.5035.9224.10171.4889.86113.77545.30-78.55250.14561.0588.68-71.65-1.16108.28
Surprise------------------------------27.74%17.19%-3.06%-36.79%-5.61%-------------------------------------
Timing------------------------Pre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-market-Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-market---Pre-market----------

Key Statistics & Ratios

Market Cap83.21B
Enterprise Value105.70B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.77
Price / Book0.57
Revenue (TTM)91.96B
Gross Profit (TTM)23.45B
EBITDA12.31B
Profit Margin5.21%
Operating Margin10.06%
Return on Equity713.04%
Return on Assets3.40%
Shares Outstanding11.09M
Shares Float5.37M
Beta0.97
Dividend Yield0.42%
Dividend Rate0.00
Payout Ratio40.27%

Dividends

20251×
50.00Dec 29, 2025
20241×
50.00Dec 27, 2024
20231×
50.00Dec 27, 2023
20221×
50.00Dec 28, 2022
20211×
50.00Dec 29, 2021
20201×
50.00Dec 29, 2020
20191×
50.00Dec 27, 2019
20181×
50.00Dec 27, 2018
20171×
50.00Dec 27, 2017
20161×
50.00Dec 28, 2016
20151×
50.00Dec 29, 2015
20141×
50.00Dec 29, 2014
20131×
50.00Dec 27, 2013
20121×
50.00Dec 27, 2012
20111×
50.00Dec 28, 2011
20101×
62.50Dec 29, 2010
20091×
25.00Dec 29, 2009
20081×
25.00Dec 29, 2008
20071×
25.00Dec 27, 2007
20061×
50.00Dec 27, 2006
20051×
25.00Dec 28, 2005

Stock Splits

  • Mar 30, 20112:1